Growth hormone (somatropin)
Contents
Description
Somatropin is a recombinant human growth hormone used to treat growth failure in children with various conditions including chromosomal abnormalities and skeletal dysplasias. It stimulates linear growth and increases growth rate in pediatric patients. In chromosome 9p deletion syndrome and omodysplasia, growth hormone therapy may be considered for short stature management when growth hormone deficiency is documented.
Indications & Therapeutic Use
growth hormone deficiency, short stature associated with chromosomal abnormalities, Turner syndrome, Prader-Willi syndrome, skeletal dysplasias with documented growth hormone deficiency
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Growth hormone (somatropin) — GNH India
208 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Growth hormone (somatropin) |
| Brands | 1 brand available |
| Active Ingredient | Somatropin |
| Drug Class | growth hormone deficiency |
| Manufacturer | Pfizer |
| Dosage Forms | Subcutaneous injection, 5mg, 12mg cartridges |
| Medical Code | H01AC01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00001345 |
| Countries | 8 countries |